A study found that novel gene therapy to be an effective treatment for patients with a specific form of autosomal recessive deafness caused by mutations of the OTOF gene, called DFNB9. The first human clinical trial to administer gene therapy for treating this condition, with the most patients treated and longest follow-up to date, and published in The Lancet.